• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Safety and Efficacy of Ticagrelor Monotherapy According to Drug-Eluting Stent Type: The TWILIGHT-STENT Study
CONCLUSIONS: As compared with ticagrelor plus aspirin, ticagrelor monotherapy after a short DAPT duration lowered bleeding complications without increasing the ischemic risk, irrespective of DES type. We observed no significant differences among DES-types.PMID:34881696 | DOI:10.4244/EIJ-D-21-00721
Source: EuroIntervention - December 9, 2021 Category: Cardiovascular & Thoracic Surgery Authors: George Dangas Usman Baber Samin K Sharma Gennaro Giustino Samantha Sartori Johny Nicolas Ridhima Goel Shamir R Mehta David J Cohen Dominick J Angiolillo Zhongjie Zhang Anton Camaj Davide Cao Carlo Briguori Dariusz Dudek Javier Escaned Kurt Huber Timothy C Source Type: research

Safety of Early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study
CONCLUSIONS: Nationwide observational data suggests that early discharge of low-risk patients with STEMI treated with PCI is not associated with an increase in 1-year MACE.PMID:34338642 | DOI:10.4244/EIJ-D-21-00501
Source: EuroIntervention - August 2, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Troels Yndigegn Patrick Gilje Josef Dankiewicz Arash Mokhtari Nazim Isma Jasminka Holmqvist Alexandru Schiopu Annika Ravn-Fischer Robin Hofmann Karolina Szummer Tomas Jernberg Stefan K James Chris P Gale Ole Fr öbert Moman A Mohammad Source Type: research

Geographical variations in left main coronary artery revascularisation: a pre-specified analysis of the EXCEL trial
CONCLUSIONS: In the EXCEL trial, the relative risks for the 30-day and five-year primary composite outcome of death, MI or stroke after PCI versus CABG were consistent irrespective of geography. However, five-year rates of IDR after PCI were significantly higher in NA centres, a finding the Heart Team and patients should consider when making treatment decisions. ClinicalTrials.gov identifier: NCT01205776.PMID:34212863 | DOI:10.4244/EIJ-D-21-00338
Source: EuroIntervention - July 2, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Aung Myat David Hildick-Smith Adam J de Belder Uday Trivedi Aaron Crowley Marie-Claude Morice David E Kandzari Nicholas J Lembo W Morris Brown Patrick W Serruys Arie Pieter Kappetein Joseph F Sabik Gregg W Stone Source Type: research

Clopidogrel Monotherapy in Patients with and without On-Treatment High Platelet Reactivity: a SMART-CHOICE sub-study
CONCLUSIONS: Clopidogrel monotherapy showed treatment effects comparable to DAPT for MACCE in patients with or without HPR. However, HPR was significantly associated with an increased risk of MACCE in clopidogrel-treated patients regardless of maintenance of aspirin.PMID:34031020 | DOI:10.4244/EIJ-D-21-00223
Source: EuroIntervention - May 25, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Seung Hun Lee Sang Yeub Lee Woo Jung Chun Young Bin Song Seung-Hyuk Choi Jin-Ok Jeong Seok Kyu Oh Kyeong Ho Yun Young-Youp Koh Jang-Whan Bae Jae Woong Choi Hyeon-Cheol Gwon Joo-Yong Hahn Source Type: research

Pages: 1  2  3  4  5  6